Cargando…
Real-time and automated monitoring of antischistosomal drug activity profiles for screening of compound libraries
Schistosomiasis is a neglected tropical disease that affects over 200 million people annually. As the antischistosomal drug pipeline is currently empty, repurposing of compound libraries has become a source for accelerating drug development, which demands the implementation of high-throughput and ef...
Autores principales: | Ravaynia, Paolo S., Biendl, Stefan, Grassi, Francesco, Keiser, Jennifer, Hierlemann, Andreas, Modena, Mario M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976133/ https://www.ncbi.nlm.nih.gov/pubmed/35378863 http://dx.doi.org/10.1016/j.isci.2022.104087 |
Ejemplares similares
-
In vitro and in vivo antischistosomal activity of ferroquine derivatives
por: Keiser, Jennifer, et al.
Publicado: (2014) -
Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity
por: Botros, Sanaa S., et al.
Publicado: (2019) -
Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
por: Angeli, Andrea, et al.
Publicado: (2022) -
Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice
por: Keiser, Jennifer, et al.
Publicado: (2009) -
Targeting the Schistosoma mansoni nutritional mechanisms to design new antischistosomal compounds
por: Pavani, Thaís F. A., et al.
Publicado: (2023)